Preoperative Ginger for the Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Laparoscopic Cholecystectomy: A Double-Blind Randomized Controlled Trial
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 4
SUMMARY
This study aims to evaluate whether preoperative oral administration of ginger (800 mg, given 2 hours before surgery) reduces the incidence and severity of postoperative nausea and vomiting (PONV) within the first 24 hours after laparoscopic cholecystectomy.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Age ≥ 18 years.
• Scheduled for elective laparoscopic cholecystectomy under general anesthesia.
• American Society of Anesthesiologists (ASA) physical status I-III.
• Able to understand the study procedures and provide written informed consent.
Locations
Other Locations
Tunisia
Mohamed Taher Maamouri University Hospital
RECRUITING
Nabeul
Contact Information
Primary
Ibtissem BEN TALEB, M.D.
ibtissem.bentaleb@fmt.utm.tn
+216 23 133 748
Time Frame
Start Date: 2025-07-05
Estimated Completion Date: 2026-12
Participants
Target number of participants: 102
Treatments
Active_comparator: Ginger group
Patients will receive 800 mg of oral ginger 2 hours before laparoscopic cholecystectomy
Placebo_comparator: Placebo group
Patients will receive an oral placebo capsule identical in appearance to ginger, administered 2 hours before laparoscopic cholecystectomy
Related Therapeutic Areas
Sponsors
Leads: University Tunis El Manar